{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-23-001560","form_type":"8-K","ticker":"CVSA","cik":"0000730464","company_name":"Covista Inc.","filed_at":"2023-10-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.854554+00:00","generated_at":"2026-06-09T09:09:56.526400+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Adtalem Q1 FY2024: revenue $368.8M, adjusted EPS $0.93; FY guidance raised","bullets":["GAAP net income $10.6M ($0.25 diluted EPS); adjusted EPS $0.93, up 3.3% YoY.","Total enrollment 81,073 (+1.9% YoY); Chamberlain up 5.2%, Walden up 0.5%.","FY2024 guidance raised: revenue $1,470-1,530M; adjusted EPS $4.25-4.45.","Repurchased $92M of shares under $300M board authorization; net leverage 1.3x.","Medical/Vet segment revenue down 3.8%, enrollment down 7.5% YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-23-001560","json":"https://secwatch.observer/filing/0001157523-23-001560.json","markdown":"https://secwatch.observer/filing/0001157523-23-001560.md","text":"https://secwatch.observer/filing/0001157523-23-001560.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/730464/000115752323001560/0001157523-23-001560-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/730464/000115752323001560/a53684541.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T09:09:56.526400+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fe405e61682e4f8d4ffe83c762a0d20e8f585e29","claim":"Covista Inc. reported first quarter fiscal 2024 results: revenue $368.8 million, net income $10.6 million, EPS $0.25. Guidance raised.","evidence_excerpt":"Raises fiscal year 2024 revenue guidance to a range of $1,470 million to $1,530 million and Adjusted EPS guidance to a range of $4.25 to $4.45 First quarter highlights Revenue $368.8 million, up 4.1% year-over-year Total student enrollment 81,073, up 1.9% year-over-year Chamberlain University third straight quarter of total enrollment growth, up 5.2% year-over-year","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/730464/000115752323001560/0001157523-23-001560-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter fiscal 2024"},{"label":"Revenue","value":"$368.8 million"},{"label":"Net income","value":"$10.6 million"},{"label":"EPS","value":"$0.25"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}